OSCR

Development of a metabolic subtype classifier for low-grade glioma to guide precision therapy.

Overview

Authors: Yiqi Tan1, Le Zeng1, Ganghua Zhang1, Jianing Fang1, Zhijing Yin1, Wenzhi Deng2, Ke Cao1, Jiaode Jiang3
  1. Department of Oncology, Third Xiangya Hospital, Central South University, Changsha, China
  2. Department of Pathology, Third Xiangya Hospital, Central South University, Changsha, China
  3. Department of Neurosurgery, Third Xiangya Hospital, Central South University, Changsha, China
Journal: Discover oncology, volume 17, issue 1, article 844
Dates: received 4 October 2025; accepted 31 March 2026; published online 21 April 2026
Type: Research article · Language: English
License: CC BY-NC-ND
Identifiers: DOI 10.1007/s12672-026-04935-z · PMID 42014657 · PMCID PMC13234030 · OpenAlex W4417368930
Open access: gold, a free copy (OpenAlex)
Status: code verified (how the code is found and verified)
Categories: human (organism), other condition (population), clinical / translational (subfield)
Methods: Statistics, Smoothing, state filtering, decompositions, Machine learning, Connectivity
Keywords: Low-grade glioma;, Metabolism, Machine learning, Artificial neural network, Prognosis
Topic: Glioma Diagnosis and Treatment (Oncology, Medicine), according to OpenAlex
Funding: natural science foundation of hunan province (2024JJ3044, 2024JJ5534); Major Scientific Research Project for High-Level Talents in Health of Hunan Province (20230566); the Hunan Provincial Postgraduate Research and Innovation Project (2025ZZTS0881); National Natural Science Foundation of China (82473260); the Key Scientific Research Project in Health of Hunan Province (20257668); he Wisdom Accumulation and Talent Cultivation Project of the Third Xiangya Hospital of Central South University (BJ202001)
Citations: not cited yet (Europe PMC); 26 references in the paper

Abstract

The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.

Code

No file of the authors' code could be read here: it is described below, and read at its source.

jianguoyun.com/p/dzy6btiqjnlpchiz6oogiaa](https:

License: none: the authors keep all their rights
State: the link answers, verified on 29 September 2026
Evidence: the link answers
Software Heritage: not checked
Found in: “Data availability”
Not found: README, license file, CITATION.cff, environment file, tests, continuous integration, documentation
Availability: 1 check, the latest on 29 September 2026: the link answers (HTTP 200)
  • 29 September 2026: the link answers (HTTP 200)

The paper's code and data availability statement is in the Data section.

Tracing map

Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.

What the map holds:

  • 1 repository of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
  • 0 scripts, each with its path and the digest of its content;
  • no match between paragraphs and code yet;
  • neither the text of the paper nor the code itself.

Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.

Data

No dataset and no data link were found in the paper.

Code and data availability statement

The paper has a code and data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:

Read it in the paper: doi.org/10.1007/s12672-026-04935-z.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 29 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 8 authors, 5 keywords, 6 funders, 26 references.

Cite

This paper

Tan, Y., Zeng, L., Zhang, G., Fang, J., Yin, Z., Deng, W., Cao, K., & Jiang, J. (2026). Development of a metabolic subtype classifier for low-grade glioma to guide precision therapy. Discover oncology, 17(1), 844. https://doi.org/10.1007/s12672-026-04935-z

BibTeX

@article{tan2026development,
author = {Tan, Yiqi and Zeng, Le and Zhang, Ganghua and Fang, Jianing and Yin, Zhijing and Deng, Wenzhi and Cao, Ke and Jiang, Jiaode},
title = {{Development of a metabolic subtype classifier for low-grade glioma to guide precision therapy}},
journal = {Discover oncology},
year = {2026},
month = apr,
volume = {17},
number = {1},
pages = {844},
publisher = {Springer},
issn = {2730-6011},
doi = {10.1007/s12672-026-04935-z},
url = {https://doi.org/10.1007/s12672-026-04935-z},
pmid = {42014657},
pmcid = {PMC13234030}
}

RIS

TY - JOUR
AU - Tan, Yiqi
AU - Zeng, Le
AU - Zhang, Ganghua
AU - Fang, Jianing
AU - Yin, Zhijing
AU - Deng, Wenzhi
AU - Cao, Ke
AU - Jiang, Jiaode
TI - Development of a metabolic subtype classifier for low-grade glioma to guide precision therapy
T2 - Discover oncology
J2 - Discov Oncol
PY - 2026
DA - 2026/04/21
VL - 17
IS - 1
SP - 844
SN - 2730-6011
PB - Springer
DO - 10.1007/s12672-026-04935-z
UR - https://doi.org/10.1007/s12672-026-04935-z
LA - en
ER -

CSL-JSON

{
"id": "10.1007/s12672-026-04935-z",
"type": "article-journal",
"title": "Development of a metabolic subtype classifier for low-grade glioma to guide precision therapy",
"container-title": "Discover oncology",
"author": [
{
"family": "Tan",
"given": "Yiqi"
},
{
"family": "Zeng",
"given": "Le"
},
{
"family": "Zhang",
"given": "Ganghua"
},
{
"family": "Fang",
"given": "Jianing"
},
{
"family": "Yin",
"given": "Zhijing"
},
{
"family": "Deng",
"given": "Wenzhi"
},
{
"family": "Cao",
"given": "Ke"
},
{
"family": "Jiang",
"given": "Jiaode"
}
],
"container-title-short": "Discov Oncol",
"volume": "17",
"issue": "1",
"page": "844",
"DOI": "10.1007/s12672-026-04935-z",
"PMID": "42014657",
"PMCID": "PMC13234030",
"ISSN": "2730-6011",
"publisher": "Springer",
"URL": "https://doi.org/10.1007/s12672-026-04935-z",
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
21
]
]
}
}

The tracing map gets a citation of its own once an author has validated it and it has a DOI.

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1111/jcmm.71154
Mitophagy-Oxidative Stress Molecular Subtypes Define an Immunosuppressive Ecosystem and Vulnerabilities in Glioblastoma.
Journal: Journal of cellular and molecular medicine
In common: other condition, 3 references
[2] doi:10.3390/brainsci12060700
A Novel Classification Model for Lower-Grade Glioma Patients Based on Pyroptosis-Related Genes.
Journal: Brain sciences
In common: other condition, 3 references
[3] doi:10.1002/cam4.6752
Identification of FXYD6 as the novel biomarker for glioma based on differential expression and DNA methylation.
Journal: Cancer medicine
In common: clinical / translational, other condition, 3 references
[4] doi:10.3390/cancers18132092
TGFB2 as a Prognostic Biomarker Associated with Myeloid-Enriched, Multi-Checkpoint-Activated Immunosuppression in Diffuse Glioma: A Multi-Cohort Transcriptomic Study.
Journal: Cancers
In common: other condition, 3 references
[5] doi:10.3389/fimmu.2024.1467858
Application of a risk score model based on glycosylation-related genes in the prognosis and treatment of patients with low-grade glioma.
Journal: Frontiers in immunology
In common: other condition, 2 references
[6] doi:10.3390/antiox12010186
Identification of Lipocalin 2 as a Ferroptosis-Related Key Gene Associated with Hypoxic-Ischemic Brain Damage via STAT3/NF-κB Signaling Pathway.
Journal: Antioxidants (Basel, Switzerland)
In common: other condition, 2 references
[7] doi:10.3390/biology15080633
Development and Validation of a Toxoplasma Infection-Associated Risk Model for Prognostic Stratification and Treatment Guidance in Glioma.
Journal: Biology
In common: clinical / translational, other condition, 2 references
[8] doi:10.3390/cancers16091723
Integration of Computational Pipeline to Streamline Efficacious Drug Nomination and Biomarker Discovery in Glioblastoma.
Journal: Cancers
In common: clinical / translational, other condition, 2 references
[9] doi:10.1186/s12885-023-10883-6
ZDHHC15 promotes glioma malignancy and acts as a novel prognostic biomarker for patients with glioma.
Journal: BMC cancer
In common: other condition, 2 references
[10] doi:10.1002/cam4.71454
TMEM106A as a Macrophage-Associated Biomarker of Prognosis in IDH-Wildtype Glioma: Integrative Multi-Omics and Spatial Analyses.
Journal: Cancer medicine
In common: clinical / translational, other condition, 2 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Add the badge to the code's README

OSCR: the badge of this paper

If you are an author or a maintainer of this paper's code, you can add this badge. It says what OSCR knows of the paper (its code, its validated tracing map) and links the code to this page. Paste one of these snippets under the README's title. Keep the two marks around it, so that the badge can be replaced in place and is never added twice. OSCR changes nothing in your repository.

Markdown
<!-- oscr-badge:start -->
[![OSCR](https://openscicode.org/badge/doi/10.1007/s12672-026-04935-z.svg)](https://openscicode.org/badge/doi/10.1007/s12672-026-04935-z)
<!-- oscr-badge:end -->
reStructuredText
.. oscr-badge:start

.. image:: https://openscicode.org/badge/doi/10.1007/s12672-026-04935-z.svg
   :target: https://openscicode.org/badge/doi/10.1007/s12672-026-04935-z
   :alt: OSCR

.. oscr-badge:end
HTML
<!-- oscr-badge:start -->
<a href="https://openscicode.org/badge/doi/10.1007/s12672-026-04935-z"><img src="https://openscicode.org/badge/doi/10.1007/s12672-026-04935-z.svg" alt="OSCR"></a>
<!-- oscr-badge:end -->

If you choose to, you can have the badge kept up to date for you, with oscr badge --write from the command line or with the GitHub Action in your repository's workflows. Every other form and option (a card, AsciiDoc, LaTeX, shields.io) is on the badge page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Report a mismatch between the code and the paper · Report a code error (signed in)

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Report a reproduction failure (signed in)

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.